18 February 2021

APLAR Biologics Conditions

Rationale behind ACR COVID vaccine guidelines

8 February 2021

Biologics COVID-19

Rheumatic disease and COVID-19 mortality

8 February 2021

Biologics Conditions

Medication review neglected in aged care

8 February 2021

COVID-19 DMARDS

Even Sportsbet won’t back the COVID vaccination deadline

8 February 2021

Biologics Gout TGA

Tofacitinib safety for RA in doubt

3 February 2021

NSAIDS

Bad medical takes

3 February 2021

AHPRA AMA Medications

Workplace bullying culture continues for doctors in training

3 February 2021

Biologics Spondyloarthritis

Can synovial biopsies predict RA treatment response?

27 January 2021

NSAIDS

New Year, New Memes

27 January 2021

Biologics COVID-19

Gout drug for Covid gets press release treatment

18 December 2020

Biologics Spondyloarthritis

Gilead will not pursue FDA approval of filgonitib for RA

15 December 2020

Analgesics Conditions Spondyloarthritis

Vagus nerve stimulation for RA symptom control

3 December 2020

Medications

Patients lose choice of assessor in NDIS reforms

3 December 2020

Analgesics Conditions Spondyloarthritis

Battle of the monotherapies: etanercept vs methotrexate

3 December 2020

Analgesics Conditions Lupus

Ixekizumab PBS-subsidised for AS

3 December 2020

Ankylosing Spondylitis Biologics Corticosteroids Juvenile Arthritis Medications

‘Absolutely invaluable’, ‘Big-Brother like’: ARA initiative sparks controversy